The Swiss online pharmacy To the Rose sees an attack by the German Federal government is exposed to. The mind that foreign online pharmacies can provide To the-Rose-the daughter of Doc Morris in the distribution of prescription drugs patients a price discount. German pharmacies are not allowed to. They are tied to the price of loyalty, which applies in Germany.
to impose in Order To Rose, the unit price, the German Minister of health, Jens Spahn, a Trick. He wants to delete the default for the single medication price from the medicine, law and the social law transfer. There, EU member States have more leeway.
For Rose would be this painful. In Germany, the Swiss online market leader makes least 671 million Swiss francs in turnover in Switzerland in the past year, 527 million. The growth in the main market is now in danger? The-Rose-in-chief Walter Oberhänsli from the waves. Spahns project would contradict clearly the requirements of the EU Commission. Also: "We believe that after the introduction of the electronic prescription bonuses with a lower importance", Oberhänsli.
Increasing online trade
In Germany has slowed, according to Oberhänsli, the growth in prescription products in the fourth quarter, despite discounts. More important than the bonuses the electronic prescription, and to come in Germany in 2020. Thus, patients can obtain their medicines from an online pharmacy. Oberhänsli hopes that, in Germany, the proportion of by shipping-related medications from the current 1.3 percent, rises to 10 percent. This share of online shipping, for example, in Switzerland, where there are E-recipes. Analysts consider this to be a credible scenario.
The legal skirmish with Berlin Oberhänsli not distract, its market leadership in Europe. Since the IPO in 2017 has taken To the Rose four competitors. With the purchase of the Spanish market place Promofarma the Thurgau-based company is now working to expand the business model.
image to enlarge
so Far, runs To Rose with a web store for prescription and over-the-counter medications and supplies to patients and Doctors and from its logistics center. Now, turning To Rose with the Spanish subsidiary of the marketplace concept: the company operates only in the Webshop. On these various product providers to register, and they will deal with the shipping.
The Rose converts to in the footsteps of Alibaba and Amazon . The US online giant, there are already more than half of the sales from the company's own Store, but on Amazon registered dealers.
The advantage: "We can expand with Promofarma our product offering and faster into new countries to advance shot," says Oberhänsli. The Thurgauer expand using your Spanish new advertising now to France and Italy – without the first, even the expensive logistics of delivery to to maintain. Even analysts are full of praise: "The expansion of the business model in the direction of marketplace is brilliant," says Sibylle Bischofberger, analyst at the Zürcher Kantonalbank .
large shareholder rises from
First of all, the Spanish subsidiary sold in the new markets only care and beauty products. Here, the pressure on margins is great, but there are no regulatory hurdles. Is established the online marketplace, it can Oberhänsli hang later prescription drugs it. The most important resource, the customer connections, is already there.
Oberhänsli wants to quickly expand. "In the E-Commerce, the rule is that The winner takes it all", he explains. "It makes sense, actively participating in market consolidation," said ZKB analyst Bischofberger, because Rose is a much more dangerous opponent threatens the Federal government in Berlin: Amazon. The U.S. giant has entered the United States into the pharmacy business. And it seems to be only a matter of time until Amazon has also ventured in Europe. "Should Amazon get in Europe into the pharmacy business, so I reckon that this is done via a Takeover," says Oberhänsli.
Now the largest shareholder has, the KWE Beteiligungen AG, which belongs to Vanessa Frey, cold feet. Frey and KWE representative for Heinz Baumgartner retire at the next annual General meeting of the Board of Directors. "The type and speed of the growth strategy" were the reason for the rift. KWE holds 10.5 per cent For Rose. Whether Frey sold the shares, is open. "I can take no position," says Oberhänsli. Also Frey is silent. Recently, the company has a new shareholder. According to the financial portal "The Market" has entered the activist Investor Veraison.
Created: 14.04.2019, 18:07 PM